X4 Pharmaceuticals (XFOR) PT Lowered to $15 at Citi
Tweet
Share
E-mailGet Alerts XFOR Hot Sheet
Price: $4.22 --0%
Rating Summary:
13 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 19
Rating Summary:
13 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 19
Join SI Premium – FREE
Citi analyst Joel Beatty lowered the price target on X4 Pharmaceuticals (NASDAQ: XFOR) to $15.00 (from $16.00) while maintaining a Buy rating.
You May Also Be Interested In
- Deutsche Bank Downgrades Workday (WDAY) to Hold
- Okta, Inc (OKTA) PT Raised to $160 at TD Cowen
- QBE Insurance Group Ltd. (QBE:AU) (QBEIF) PT Lowered to AUD23.40 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
